Similarly, it has been observed that specific inhibition of UHRF1, by mRNA targeting, decreased the oncogenic capacity in breast cancer cells and increased their sensitivity to chemotherapy [101, 102]. This evidence concerns the gene UHRF1 and breast carcinoma.